跳至主要内容
临床试验/NCT00233558
NCT00233558终止4 期

Multicentre, Randomised, Open Label Study Comparing a "Scheduled Steroid Reduction Strategy" Versus a Free Steroid Reduction Strategy (Physician's Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months

Abbott2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2005年6月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
发起方
Abbott
入组人数
160
试验地点
2
主要终点
Corticoid reduction and DAS 28

研究概览

简要总结

The purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTX

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is age 18 or older and in good health (Investigator discretion) with a recent stable medical history
  • Subject has a diagnosis of rheumatoid arthritis as defined by the 1987-revised ACR criteria

排除标准

  • Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
  • Female subject who is pregnant or breast-feeding or considering becoming pregnant

结局指标

主要结局

Corticoid reduction and DAS 28

次要结局

  • Patient reported outcomes
  • Clinical response indicators
  • Safety parameters

研究者

发起方
Abbott
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验